全文获取类型
收费全文 | 2830篇 |
免费 | 154篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 78篇 |
妇产科学 | 64篇 |
基础医学 | 442篇 |
口腔科学 | 31篇 |
临床医学 | 219篇 |
内科学 | 678篇 |
皮肤病学 | 53篇 |
神经病学 | 382篇 |
特种医学 | 61篇 |
外科学 | 222篇 |
综合类 | 3篇 |
一般理论 | 1篇 |
预防医学 | 140篇 |
眼科学 | 21篇 |
药学 | 218篇 |
中国医学 | 28篇 |
肿瘤学 | 351篇 |
出版年
2024年 | 5篇 |
2023年 | 26篇 |
2022年 | 55篇 |
2021年 | 84篇 |
2020年 | 55篇 |
2019年 | 46篇 |
2018年 | 78篇 |
2017年 | 65篇 |
2016年 | 55篇 |
2015年 | 89篇 |
2014年 | 91篇 |
2013年 | 140篇 |
2012年 | 220篇 |
2011年 | 212篇 |
2010年 | 112篇 |
2009年 | 110篇 |
2008年 | 208篇 |
2007年 | 237篇 |
2006年 | 205篇 |
2005年 | 169篇 |
2004年 | 181篇 |
2003年 | 139篇 |
2002年 | 112篇 |
2001年 | 23篇 |
2000年 | 20篇 |
1999年 | 19篇 |
1998年 | 27篇 |
1997年 | 16篇 |
1996年 | 23篇 |
1995年 | 18篇 |
1994年 | 11篇 |
1993年 | 6篇 |
1992年 | 13篇 |
1991年 | 24篇 |
1990年 | 19篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 7篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1975年 | 4篇 |
1974年 | 2篇 |
1973年 | 4篇 |
1971年 | 3篇 |
1970年 | 2篇 |
1969年 | 2篇 |
排序方式: 共有2999条查询结果,搜索用时 15 毫秒
71.
Piero Barbanti MD PhD Cinzia Aurilia MD Sabina Cevoli MD PhD Gabriella Egeo MD PhD Luisa Fofi MD Roberta Messina MD Antonio Salerno MD Paola Torelli MD Maria Albanese MD PhD Antonio Carnevale MD Francesco Bono MD Domenico D'Amico MD Massimo Filippi MD Claudia Altamura MD PhD Fabrizio Vernieri MD EARLY Study Group 《Headache》2021,61(9):1351-1363
72.
Susanna Millanta Anna Lisa Furfaro Paolo Carlier Bruno Tasso Mariapaola Nitti Cinzia Domenicotti Patrizio Odetti Maria Adelaide Pronzato Nicola Traverso 《Experimental and molecular pathology》2013
Malondialdehyde (MDA), a major lipid peroxidation product, spontaneously binds to, and modifies proteins. In vivo, proteins are physiologically exposed to micromolar MDA concentrations for long periods. In order to mimic this process in vitro, protein modification is often performed by short exposure to millimolar MDA concentrations, also in order to generate antigenic structures for antibody production. 相似文献
73.
Alessandra Battaglia Alexia Buzzonetti Cinzia Baranello Mara Fanelli Marco Fossati Valentina Catzola Giovanni Scambia Andrea Fattorossi 《Immunology》2013,139(1):109-120
Interleukin‐2 (IL‐2) is a mainstay for current immunotherapeutic protocols but its usefulness in patients is reduced by severe toxicities and because IL‐2 facilitates regulatory T (Treg) cell development. IL‐21 is a type I cytokine acting as a potent T‐cell co‐mitogen but less efficient than IL‐2 in sustaining T‐cell proliferation. Using various in vitro models for T‐cell receptor (TCR)‐dependent human T‐cell proliferation, we found that IL‐21 synergized with IL‐2 to make CD4+ and CD8+ T cells attain a level of expansion that was impossible to obtain with IL‐2 alone. Synergy was mostly evident in naive CD4+ cells. IL‐2 and tumour‐released transforming growth factor‐β (TGF‐β) are the main environmental cues that cooperate in Treg cell induction in tumour patients. Interleukin‐21 hampered Treg cell expansion induced by IL‐2/TGF‐β combination in naive CD4+ cells by facilitating non‐Treg over Treg cell proliferation from the early phases of cell activation. Conversely, IL‐21 did not modulate the conversion of naive activated CD4+ cells into Treg cells in the absence of cell division. Treg cell reduction was related to persistent activation of Stat3, a negative regulator of Treg cells associated with down‐modulation of IL‐2/TGF‐β‐induced phosphorylation of Smad2/3, a positive regulator of Treg cells. In contrast to previous studies, IL‐21 was completely ineffective in counteracting the suppressive activity of Treg cells on naive and memory, CD4+ and CD8+ T cells. Present data provide proof‐of‐concept for evaluating a combinatorial approach that would reduce the IL‐2 needed to sustain T‐cell proliferation efficiently, thereby reducing toxicity and controlling a tolerizing mechanism responsible for the contraction of the T‐cell response. 相似文献
74.
Antonio Strillacci Maria Chiara Valerii Pasquale Sansone Cinzia Caggiano Annamaria Sgromo Laura Vittori Michelangelo Fiorentino Gilberto Poggioli Fernando Rizzello Massimo Campieri Enzo Spisni 《The Journal of pathology》2013,229(3):379-389
Colorectal cancer (CRC) is the second leading cause of cancer‐related mortality in Western countries. Although the aberrant expression of several microRNAs (oncomiRs) is associated with CRC progression, the molecular mechanisms of this phenomenon are still under investigation. Here we show that miR‐101 expression is differentially impaired in CRC specimens, depending on tumour grade. miR‐101 re‐expression suppresses cell growth in 3D, hypoxic survival and invasive potential in CRC cells showing low levels of miR‐101. Additionally, we provide molecular evidence of a bidirectional regulatory mechanism between miR‐101 expression and important CRC pro‐malignant features, such as inflammation, activation of the Wnt/β‐catenin signalling pathway and epithelial–mesenchymal transition (EMT). We then propose that up‐regulated miR‐101 may function as a tumour suppressor in CRC and that its pharmacological restoration might hamper the aggressive behaviour of CRC in vivo. MiR‐101 expression may also represent a cancer biomarker for CRC diagnosis and prognosis. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 相似文献
75.
Cristina Costa Samantha Mantovani Cinzia. Balloco Francesca Sidoti Fabrizio Fop Rossana Cavallo 《Journal of virological methods》2013
Quantitative detection of human cytomegalovirus (HCMV) DNA on whole blood is currently the primary choice for virological monitoring in transplant patients and for determining the appropriate antiviral strategy, however specific issues of variability remain in terms of extraction methods, amplification efficiency, and variability. This study compared the performance characteristics of two nucleic acid extraction and testing systems for HCMV-DNA quantitation, the artus® CMV QS-RGQ kit, associated with a fully automated DNA extraction and assay set up by Qiagen (system 1) and the Q-CMV Real Time Complete kit by Nanogen, associated with a semiautomated nucleic acid extraction system by Biomérieux (system 2) in 189 specimens from transplant patients and 10 from 2012 HCMV Quality Control for Molecular Diagnostics (QCMD). The two systems exhibited a 80.4% concordance. Differences between the two systems were within ±1 log10 copies/ml of the averaged log10 results for 88.9% of the tested specimens. For all qualitatively discordant specimens, mean viral load was ≤3 log10 copies/ml. Considering viral load measurement, system 1 gave earlier positives that system 2, with a 14.8% of specimens resulted positive at low viral loads with system 1 and negative with system 2. In QCMD specimens, difference was below 0.7 log10 copies/ml for both the systems. 相似文献
76.
77.
Cristina Costa Antonio Curtoni Francesca Sidoti Cinzia Balloco Salvatore Simeone Samantha Mantovani Elsa Piasentin Alessio Daniela Libertucci Luisa Delsedime Paolo Solidoro Sergio Baldi Rossana Cavallo 《Archives of virology》2013,158(7):1461-1465
The role of human cytomegalovirus (HCMV) in lung transplantation (LT) and drawbacks related to viral quantification in bronchoalveolar lavage (BAL) underline the potential usefulness of investigating other specimens. Thirty-three LT recipients were prospectively studied by HCMV quantitative real time PCR on matched transbronchial biopsy (TBB), BAL, and whole blood specimens. Overall, 27/33 patients turned out HCMV-positive in at least one specimen: 7.1 %, 37.1 %, and 13.5 % of TBB, BAL, and blood samples, respectively. No significant association between HCMV on all types of specimens and acute rejection, lymphocytic bronchiolitis, bronchiolitis obliterans and bronchiolitis obliterans syndrome was found. HCMV pneumonia was associated to HCMV detection on TBB (p = 0.003) and whole blood (p = 0.008), not on BAL (p = 0.47). The highest mean viral load was detected in TBB from cases with HCMV pneumonia in comparison to all other cases, suggesting the potential use of HCMV investigation in TBB for evaluating posttransplant complications. 相似文献
78.
Grazia P. Nicchia Cinzia Stigliano Angelo Sparaneo Andrea Rossi Antonio Frigeri Maria Svelto 《Journal of molecular medicine (Berlin, Germany)》2013,91(5):613-623
Prohibiting angiogenesis is an important therapeutic approach for fighting cancer and other angiogenic related diseases. Research focused on proteins that regulate abnormal angiogenesis has attracted intense interest in both academia and industry. Such proteins are able to target several angiogenic factors concurrently, thereby increasing the possibility of therapeutic success. Aquaporin-1 (AQP1) is a water channel membrane protein that promotes tumour angiogenesis by allowing faster endothelial cell migration. In this study we test the hypothesis that AQP1 inhibition impairs tumour growth in a mouse model of melanoma. After validating the inhibitor efficacy of two different AQP1 specific siRNAs in cell cultures, RNA interference experiments were performed by intratumoural injections of AQP1 siRNAs in mice. After 6 days of treatment, AQP1 siRNA treated tumours showed a 75 % reduction in volume when compared to controls. AQP1 protein level, in AQP1 knockdown tumours, was around 75 % that of the controls and was associated with a significant 40 % reduced expression of the endothelial marker, Factor VIII. Immunofluorescence analysis of AQP1 siRNA treated tumours showed a significantly lower microvessel density. Time course experiments demontrated that repeated injections of AQP1 siRNA over time are effective in sustaining the inhibition of tumour growth. Finally, we have confirmed the role of AQP1 in sustaining an active endothelium during angiogenesis and we have shown that AQP1 reduction causes an increase in VEGF levels. In conclusion, this study validates AQP1 as a pro-angiogenic protein, relevant for the therapy of cancer and other angiogenic-related diseases such as psoriasis, endometriosis, arthritis and atherosclerosis. 相似文献
79.
80.
Cinzia Iacopetti Ilaria Londi Valentino Patussi Fiammetta Cosci 《Clinical psychology & psychotherapy》2021,28(5):1128-1134
The family climate has notable impact on cognitive, emotional, behavioural, social and physical development of children and adolescents and can be influenced by parents' health status. The present study aimed at evaluating whether living with a parent with alcohol use disorder negatively influences the perceived emotional family climate, parental attitudes and internal representations of family relationships. Forty-five children living with a parent with alcohol use disorder and 45 controls, matched for sex and age, completed the Level of Expressed Emotion Scale and the Family Attitudes Questionnaire. Their significant parent completed the Parental Attitudes Scale. The results suggested that living with a parent with an alcohol use disorder increased the risk of having perceived higher levels of emotional response, attitude towards illness and expectations from their parents; it also increased the probability of being exposed to lower parental pleasure and of having represented worse family relationships. Emotion regulation interventions might be useful to protect children living with a parent with alcohol use disorder from a potential chaotic and unpredictable family environment. 相似文献